Skip to main content
Advertisement
Advertisement
DRUG
DRUG logo
Bright Minds Biosciences Inc. Common Stock
22.61
USD
Sponsored
-1.50
-6.22%
Nov 10, 15:59 UTC -5
Closed
exchange

After-Market

23.31

+0.70
+3.08%

Bright Minds Biosciences Inc. Common Stock (DRUG) Profile

Bright Minds Biosciences Inc. Common Stock Profile

About

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

Info & Links

CEO

Ian McDonald

Headquarters

400 N ABERDEEN ST,SUITE 900
CHICAGO, IL 60642, UNITED STATES

Sector

Medical

Auditor

De Visser Gray LLP

Share holders

--

Employees

25

Bright Minds Biosciences Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

229.90M

Enterprise Value

7.60M

Enterprise Value/EBITDA(ttm)

-0.27

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.83

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-12.46%

Return on Invested Capital(ttm)

-17.64%

Return on Assets(ttm)

-12.30%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.41M

Net Income Available to Common(ttm)

-17.72M

Diluted EPS(ttm)

-2.08

Share Statistics

Beta (5Y Monthly)

-5.11

52-Week Change

-61.54%

S&P 500 52-Week Change

16.37%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

5.58M

% Held by Insiders

42.66%

% Held by Institutions

40.52%

Balance Sheet

Total Cash(mrq)

222.34M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

47.40K

Total Debt/Equity(mrq)

0.02%

Current Ratio(mrq)

121.97%

Quick Ratio(mrq)

122.00%

Book Value Per Share(mrq)

22.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.72

Free Cash Flow(ytd)

-16.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement